Bar-Or, A., Calabresi, P.A., Arnold, D., Markowitz, C., Shafer, S., Kasper, L.H., Waubant, E., Gazda, S., Fox, R.J., Panzara, M., Sarkar, N., Agarwal, S. and Smith, C.H. (2008) Rituximab in Relapsing-Remitting Multiple Sclerosis: A 72-Week, Open-Label, Phase I Trial. Annals of Neurology, 63, 395-400. http://dx.doi.org/10.1002/ana.21363

has been cited by the following article:

• TITLE: B Cells with Regulatory Function in Animal Models of Autoimmune and Non-Autoimmune Diseases

  AUTHORS: Mei Lin, Zuomin Wang, Xiaozhe Han

  KEYWORDS: Bregs, Animal Models, IL-10, Autoimmune Disease, Immune Regulation

  JOURNAL NAME: Open Journal of Immunology, Vol.5 No.1, February 12, 2015

  ABSTRACT: Although the identification of B cell subsets with negative regulatory functions and the definition of their mechanisms of action are recent events, the important negative regulatory roles of B cells in immune responses are now broadly recognized. There is an emerging appreciation for the pivotal role played by B cells in several areas of human diseases including autoimmune diseases and non-autoimmune diseases such as parasite infections and cancer. The recent research advancement of regulatory B cells in human disease coincides with the vastly accelerated pace of research on the bridging of innate and adaptive immune system. Current study and our continued research may provide better understanding of the mechanisms that promote regulatory B10 cell function to counteract exaggerated immune activation in autoimmune as well as non-autoimmune conditions. This review is focused on the current knowledge of BREG functions studied in animal models of autoimmune and non-autoimmune diseases.